In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  selumetinib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00012, NCT00372788
2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00008, NCT00372944
3.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-2009-00604, U10CA027469, CDR0000563965, GOG-0239, NCT00551070
4.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00247, MCC#15260, CDR0000571751, N01CM62207, N01CM62208, MCC-07-0973, 7909, GCRC-2625-ORC, VU-VICC-GI-0726, 77782, NCT00550719
5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00251, 07056, N01OH62207, CDR0000573452, OSU-07056, 7932, NCT00553332
6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MCC-15305, MCC-15305, MCC-LOI-7918, 7918, NCT00559949
7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00250, N01CM62209, N01CM62201, CDR0000581297, 15455B, UCCRC-15455B, 7925, NCT00588809
8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-09003, 09-003, 8252, NCT00866177
9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09-005, NCT00888134
10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00016, NCT00890825
11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00006, NCT00936221
12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-0229H, GOG-0229H, NCT01011933
13.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-16137, 24918/1, NCI-8631, NCT01085214
14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D9010C00009, AGICC 09CRC02, NCT01116271
15.

Phase: Phase II
Type: Tissue collection/Repository, Treatment
Status: Temporarily closed
Age: Postmenopausal
Sponsor: Other
Protocol IDs: SAKK 21/08, SWS-SAKK-21/08, EUDRACT-2010-019965-27, EU-21046, CDR0000680800, NCT01160718
16.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-16066, NCI-P-8436, NCT01166126
17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: OCTO_015, NCT01256359
18.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00005, NCT00463814
19.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00004, NCT00600496
20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00020, 2007-004456-37 EudraCT Number, NCT00710515
New Search